EZH2 potential target in cutaneous basal cell carcinoma

The expression of the histone methyltransferase EZH2 correlates with aggressive subtypes of cutaneous basal cell carcinoma, highlighting the possibility that EZH2 may be an actionable target in this malignancy, say researchers.
Source: MedWire News - Category: Consumer Health News Tags: Oncology Source Type: news